Industry Speaker Series: A Parent’s Journey Through Drug Development and Wearing Many Hats with Dr. Berent, CSO of FAST

Join us for a virtual Industry Talk featuring Dr. Allyson Berent.

Berent is the Chief Science Officer for the Foundation for Angelman Syndrome Therapeutics and the Chief Operating Officer for GeneTx Biotherapeutics, developing a novel antisense olignonucleotide for the treatment of Angelman syndrome, asrare neurogenetic disorder. Berent graduated from Cornell University College of Veterinary Medicine in 2002 and completed a residency in veterinary internal medicine at the University of Pennsylvania in 2005, followed by a fellowship in interventional radiology and endourology at the University of Pennsylvania and Thomas Jefferson University. Since 2009, Berent serves as the Director of Interventional Endoscopy Services at the Animal Medical Center in New York City. 

Please come prepared to engage. Register here to receive Zoom log-in information.

The KGI Industry Speaker Series is sponsored by Wilson Sonsini. 

_{About Wilson Sonsini Goodrich & Rosati: 
For more than 60 years, Wilson Sonsini’s services and legal disciplines have focused on serving the principal challenges faced by the management and boards of directors of business enterprises. The firm is nationally recognized as a leading provider to growing and established clients seeking legal counsel to complete sophisticated corporate and technology transactions; manage governance and enterprise-scale matters; assist with intellectual property development, protection, and IP-driven transactions; represent them in contested disputes; and/or advise them on antitrust or other regulatory matters. With deep roots in Silicon Valley, Wilson Sonsini has offices in Austin; Beijing; Boston; Brussels; Hong Kong; London; Los Angeles; New York; Palo Alto; San Diego; San Francisco; Seattle; Shanghai; Washington, D.C.; and Wilmington, DE. For more information, please visit wsgr.com.}